Free Trial

Stocks open lower, still head for 3rd straight monthly gain

Currency traders watch monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, April 30, 2021. Asian shares were mostly lower Friday amid uncertainty about the prospects for a gradual global economic recovery from the coronavirus pandemic. (AP Photo/Ahn Young-joon)

Stocks were moderately lower in early morning trading on Friday, pulled down by technology and communications stocks. Despite the decline, the market is on pace for its best month so far this year, as investors remain optimistic that the pandemic is slowly and steadily coming to a close.

The S&P 500 was down 0.4% as of 10:05 a.m. Eastern. The Dow Jones Industrial Average lost 0.3% and the Nasdaq was also down 0.3%. With the exception of the Dow, the other two indexes are on pace for modest gains this week.

At this rate the S&P 500 is on track for its best month since November 2020, when President Joe Biden was elected. The benchmark index is up 5.6% this month, helped mostly by signs that large-scale coronavirus vaccination programs are helping people return to jobs and normal behaviors after more than a year of restrictions.

The Commerce Department said Thursday that the U.S. economy grew at a brisk 6.4% annual rate in the last quarter and is likely to accelerate further as more vaccinations are administered and COVID-19 cases continue to fall.

There's also the trillions of dollars in government support that has gone out to help the U.S. economy recover from the pandemic. The Commerce Department said U.S. household incomes surged 21% last month, driven largely by the $1,400 payments that went out to most Americans as part of President Biden's economic package.

Investors have also gotten strong corporate earnings which have helped justify higher stock prices. Amazon rose 2% after the e-commerce giant reported that its profits more than tripled in the latest quarter.

Investors will get another big dose of earnings reports next week, including results from drugmakers Eli Lilly, Merck as well as Pepsi, Colgate-Palmolive, the railroad CSX and drugstore giant CVS. Investors will also get April's jobs report next week.

Should you invest $1,000 in Eli Lilly and Company right now?

Before you consider Eli Lilly and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.

While Eli Lilly and Company currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Eli Lilly and Company (LLY)
4.9964 of 5 stars
$788.35-0.1%0.66%85.23Moderate Buy$1,007.94
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines